Cita APA (7a ed.)

T, L., T, J., X, Y., C, L., J, S., Z, N., . . . Y, Y. (2016). Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo. Dove Medical Press.

Cita Chicago Style (17a ed.)

T, Liu, Jia T, Yuan X, Liu C, Sun J, Ni Z, Xu J, Wang X, y Yuan Y. Development of Octreotide-conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Dove Medical Press, 2016.

Cita MLA (8a ed.)

T, Liu, et al. Development of Octreotide-conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Dove Medical Press, 2016.